Signant’s psychiatry experts and CNS thought leaders presented scientific posters at the American Society of Clinical Psychopharmacology’s 2022 annual meeting hosted in Arizona from May 31-June 3.  

Two of the posters presented original research important to understanding factors that influence data quality in clinical trials: the relationship between baseline severity of negative symptoms and end of treatment improvement in schizophrenia studies, as well as rapid recruitment in acute schizophrenia studies and associated data quality concerns. Topics also included findings from a phase 3 study on an adjunctive treatment for Major Depressive Disorder, and the validity of a new, shorter form of the PANSS scale to measure treatment sensitivity in pediatric psychopharmacology studies. 

Browse through each poster below and meet our experts

scientific poster illustrating medical research outcome for major depressive disorder randomized phase 3 placebo controlled clinical trial
scientific poster illustrating medical research outcomes in double-blind randomized controlled (RCT) trial in adolescent schizophrenia
scientific poster illustrating results of exploratory analysis of the effect of differences between PANSS score changes from baseline to baseline at last visit in schizophrenia studies
scientific poster displaying results from analysis of relationship between recruitment speed and data quality concerns in clinical trials.

Signant Health

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 20 years, over 400 sponsors and CROs of all sizes – including all of Top 20 pharma – have trusted Signant Health solutions for remote and site-based eCOA, eConsent, IRT, supply chain management, and data quality analytics.

Recent Posts

eCOA

Webinar Recap: Unleashing the Power of PROs Throughout Oncology Drug Development

Learn more

eCOA

7 eCOA Solution Design Recommendations: Applied Insights from Trial Sites and CRAs 

Learn more

General

5 Top Clinical Research Themes and Trends of 2023 (and 2024)

Learn more

eCOA

Webinar Recap: How EDC Can Support Modern Clinical Trials 

Learn more

Clinical Supplies

Bringing RTSM in From the Cold: Integrated Approaches for Optimized Trial Conduct

Learn more